MICHELLE BROKES: Open Payments
NPI 1972798353 · ELLSWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 13 payments from 9 companies in 2025. Trend: 2023 $356 · 2024 $281 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| ABBVIE INC. | 3 | $46 |
| CSL Behring | 1 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| PFIZER INC. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: LEQVIO, VRAYLAR, Andembry, GEMTESA, JARDIANCE, AIRSUPRA, PREVNAR 20, EVENITY.
Industry payments across KS — which companies pay providers there.
